


































These compounds can be considered as technological platform for nanomaterials 
design by self-assembly method. Particular attention will be paid to the application of 
calixarene derivatives for the construction of various supramolecular and nanosystems, 
devices and smart materials: colloid nanoparticles, catalytic systems, metal-
coordinated networks, Langmuir-Blodgett nanolayers, molecular magnets etc. 
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After the independent discovery of copper catalyzed azide-alkyne cycloaddition 





monocyclic, spirocyclic and fused 1,2,3-triazoles have been efficiently synthesized by 
various researchers and their biological and technical properties were widely studied 
[1,2]. Among these, the 1,2,3-triazoles linearly connected to other heterocycles were 
found to exhibit potential pharmacological and fluorophoric properties [3].  
The convenient synthesis of a variety of pharmacologically relevant 1,2,3-
triazoles derivatives linked to complex heterocyclic systems like coumarin and equol 
has been achieved [4–7]. The salient features of these developed protocols include: 
facile one-pot reactions, easy isolation process, good to excellent yield of the desired 
products and appendage diversity of substituted triazoles (Scheme 1). The obtained 
triazole products linked to coumarin were found to exhibit potent antimicrobial and 
antioxidant properties. The evaluation of biological properties of the triazoles linked to 
equol will be carried out in due course. 
 
Scheme 1. Facile one-pot synthesis of diverse 1,2,3-triazoles 
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